Loading stock data…
HealthEquity (HQY)
$87.81-0.65 (-0.73%)
After Hours$89.80+1.99 (+2.27%)· Last close Jun 29
HealthEquity, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
HealthEquity, Inc. in the Healthcare sector is trading at $87.81 with a market capitalization of $7.2B. Wall Street consensus targets $115.56 (16 analysts), implying a +31.6% move over the next 12 months. The stock is currently 18% below its 52-week high of $106.60, remaining 0.3% below its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +31.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $354.64M↑ | $334.59M↑ | $322.16M↓ | $325.83M↓ | $330.84M |
| Gross Profit | $256.31M↑ | $228.15M | $228.06M↓ | $232.59M↑ | $224.31M |
| Operating Income | $104.07M↑ | $72.39M↓ | $79.85M↓ | $90.88M↑ | $84.35M |
| Net Income | $69.42M↑ | $49.74M↓ | $51.69M↓ | $59.85M↑ | $53.91M |
Peer Comparison
JNJUNHPFE
Fundamentals
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$7.23B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.27%
Volume
Today's trading volume
899,426
Recent News
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.
Is HealthEquity's Improving Profitability Enough to Offset Key Risks?
HQY raises fiscal 2027 guidance after strong Q1 results, but custodial yield swings and cybersecurity worries remain.
The Bull Case For HealthEquity (HQY) Could Change Following Raised Earnings Outlook And Completed Buyback Program
In May 2026, HealthEquity, Inc. reported first-quarter revenue of US$354.64 million and net income of US$69.42 million, and raised its full-year fiscal 2027 earnings outlook while completing a US$244.45 million share repurchase program covering 3.33% of its shares. The company’s updated guidance, including expected fiscal 2027 net income of US$242 million to US$248 million, highlights management’s confidence in its HSA-focused model amid ongoing research showing HSAs can improve consumers’...
Zacks Industry Outlook Highlights BrightSpring Health Services, Biodesix and HealthEquity
BTSG, BDSX and HQY are positioned to benefit as digital health, analytics and patient-focused care reshape medical services.
3 Medical Service Industry Stocks Thriving Amid Workforce Challenges
BTSG, BDSX and HQY stand to benefit as digital health, healthcare analytics and nursing care growth offset workforce strains.